Diadem: The Breakthrough Wearable Revolutionizing Chronic Pain Management

Diadem, a groundbreaking wearable device, offers new hope for chronic pain sufferers.

Al Landes Avatar
Al Landes Avatar

By

Our editorial process is built on human expertise, ensuring that every article is reliable and trustworthy. AI helps us shape our content to be as accurate and engaging as possible.
Learn more about our commitment to integrity in our Code of Ethics.

Image Credit: University of Utah

Key Takeaways

  • Diadem, a wearable device, offers rapid and sustained relief for chronic pain sufferers in just one 40-minute session.
  • In a clinical trial, 60% of participants experienced clinically meaningful pain reduction lasting at least a week after a single treatment.
  • Diadem’s non-invasive, targeted approach to neuromodulation sets it apart from current treatments with limited effectiveness and side effects.

A groundbreaking wearable device, Diadem, is set to revolutionize the treatment of chronic pain, offering rapid and sustained relief in as little as one 40-minute session. This innovative technology has the potential to transform the lives of the estimated 20% to 30% of people worldwide who suffer from chronic pain conditions such as fibromyalgia, back pain, and neuropathy.

The Diadem device works by noninvasively stimulating deep brain regions involved in pain processing, potentially disrupting faulty pain signals. Unlike current treatments like medication and surgery, which often have limited effectiveness and significant side effects, Diadem has shown promising results in clinical trials.

In a recent study, 60% of participants experienced a clinically meaningful reduction in pain symptoms just one day after a single treatment session, with the effects lasting for at least a week. The device was well-tolerated, with no adverse events detected, as reported by the University of Utah. The findings are published in PAIN.

“We’ve been blown away by the positive results so far,” the paper’s lead author, Tom Riis, a postdoctoral researcher in the Department of Biomedical Engineering said as reported by New Atlas. “After just a single 40-minute stimulation session, patients are showing immediate, clinically substantial improvements in symptoms.”

As researchers prepare for a Phase 3 clinical trial, the final step before FDA approval, there is hope that Diadem could become widely available to the millions of people struggling with chronic pain. This innovative treatment also has the potential to help address the opioid crisis by reducing the need for addictive pain medications.

If you or a loved one suffers from chronic pain, keep an eye out for updates on the Diadem clinical trial and talk to your healthcare provider about potential participation. This wearable device may just be the breakthrough you’ve been waiting for.

Share this

At Gadget Review, our guides, reviews, and news are driven by thorough human expertise and use our Trust Rating system and the True Score. AI assists in refining our editorial process, ensuring that every article is engaging, clear and succinct. See how we write our content here →